Objective: Given the interest in glucagon antagonism as a potential treatment of diabetes, we tested the hypothesis that glucagon, in concert with insulin, supports the postabsorptive plasma ...

This issue of Nature Metabolism presents findings demonstrating that glucagon-like peptide-2 (GLP-2) minimizes metabolic disruptions caused by the antipsychotic olanzapine.

Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...